News | Magnetic Resonance Imaging (MRI) | February 14, 2019

Circle Cardiovascular Imaging and Galgo Medical Enter Distribution and Joint Development Agreement

Agreement will expand use of cardiac MRI to electrophysiology procedures through Circle’s cvi42 cardiovascular imaging platform and Galgo’s ADAS 3D EP planning software

Circle Cardiovascular Imaging and Galgo Medical Enter Distribution and Joint Development Agreement

February 14, 2019 – Circle Cardiovascular Imaging and Galgo Medical recently announced an agreement for distribution and joint development with respect to magnetic resonance imaging (MRI) scanner application products and workflows, with corresponding post-processing capabilities. The focus will be to improve cardiac MRI workflows and diagnostic tools to expand accessibility and use of the modality to electrophysiology procedures such as atrial fibrillation and ventricular tachycardia ablations.

The announcement was made at the Society for Cardiovascular Magnetic Resonance (SCMR) 2019 meeting, Feb. 6-9 in Bellevue, Wash.

Circle’s imaging platform, cvi42 is a cardiovascular imaging reading and reporting solution for cardiac MR, cardiac computed tomography (CT) and cardiac interventional planning. cvi42 provides physicians the tools to accurately quantify and diagnose complex cardiovascular diseases while improving patient outcomes and the effective utilization of healthcare resources. Currently at version 5.10, cvi42 utilizes machine learning and big data, with the machine results demonstrating capabilities within the same range as expert human readers.

Galgo Medical SL is a Barcelona-based company that emerged from the Department of Information Technologies (DTIC) at the Universitat Pompeu Fabra (Barcelona, Spain). Its ADAS 3D family of products is intended for the identification of arrhythmia substrate and the planning of ablation procedures using cardiac MRI and CT.                     

For more information: www.circlecvi.com, www.adas3d.com


Related Content

News | Magnetic Resonance Imaging (MRI)

May 12, 2025 — GE HealthCare recently unveiled Signa Sprint, an FDA 510(k) pending[1] ultra-premium wide bore 1.5T high ...

Home May 12, 2025
Home
News | Magnetic Resonance Imaging (MRI)

Nov. 21, 2024 — Royal Philips plans to unveil its next-generation 1.5T BlueSeal MR wide-bore scanner at RSNA 2024 in ...

Home November 21, 2024
Home
News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Home February 21, 2024
Home
News | Magnetic Resonance Imaging (MRI)

November 17, 2023 — Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy ...

Home November 17, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 28, 2023 — Liver disease, the UK’s third leading cause of premature death, poses a significantly greater threat to ...

Home June 28, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 20, 2023 — The US Food and Drug Administration has approved the use of iTFlow in blood flow analysis. The FDA ...

Home June 20, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 7, 2023 — GE HealthCare announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based ...

Home June 07, 2023
Home
Feature | Magnetic Resonance Imaging (MRI) | By Johnson Polakkal Joseph

Magnetic resonance imaging (MRI) is a technology that has been around for more than four decades and is a staple in ...

Home May 01, 2023
Home
News | Magnetic Resonance Imaging (MRI)

April 18, 2023 — Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting ...

Home April 18, 2023
Home
News | Magnetic Resonance Imaging (MRI)

April 4, 2023 — Medtronic has announced the launch of MRI Care Pathway, a new system that can streamline the process of ...

Home April 04, 2023
Home
Subscribe Now